Of 11 guidance figures from HCA Healthcare's earnings releases that Stock Atlas has scored against the reported result, 3 came in above the guide, 4 in range and 4 below. It met or beat its own guidance 64% of the time.
| Period | Measure | Guided | Reported | Result |
|---|---|---|---|---|
| FY2025 | Capital Expenditures | $5.00B | $4.94B | below |
| FY2025 | Net Income | $6.50B to $6.71B | $7.78B | above |
| FY2025 | Revenue | $75.00B to $76.50B | $75.60B | in range |
| FY2024 | Capital Expenditures | $5.00B | $4.88B | below |
| FY2024 | Net Income | $5.67B to $5.97B | $6.66B | above |
| FY2024 | Revenue | $69.75B to $71.75B | $70.60B | in range |
| FY2023 | Revenues | $63.50B to $64.50B | $64.97B | above |
| FY2022 | Revenues | $59.50B to $61.50B | $60.23B | in range |
Above means the reported figure beat the top of the range, in range that it landed inside it or on a point guide, below that it missed. Every guide and revision, and screens across companies, are in the research platform.
Do companies beat their own guidance? The study · Back to HCA Healthcare financials
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “HCA Healthcare (HCA) guidance record”, stockatlas.com/companies/HCA/guidance/, data as of 3 November 2026. Links to this page are welcome.
